Trial Profile
Real world relapse rates of glatiramer acetate patients switching to fingolimod or interferon beta-1a versus remaining on glatiramer acetate
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Glatiramer acetate (Primary) ; Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 26 Feb 2016 New trial record